- Home
- KURA vs RERE Comparison
KURA vs RERE Comparison
Compare KURA & RERE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- RERE
- Stock Information
- Founded
- KURA 2014
- RERE 2011
- Country
- KURA United States
- RERE China
- Employees
- KURA N/A
- RERE N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- RERE Other Specialty Stores
- Sector
- KURA Health Care
- RERE Consumer Discretionary
- Exchange
- KURA Nasdaq
- RERE Nasdaq
- Market Cap
- KURA 592.7M
- RERE 678.4M
- IPO Year
- KURA N/A
- RERE 2021
- Fundamental
- Price
- KURA $6.37
- RERE $2.28
- Analyst Decision
- KURA Strong Buy
- RERE
- Analyst Count
- KURA 10
- RERE 0
- Target Price
- KURA $25.50
- RERE N/A
- AVG Volume (30 Days)
- KURA 1.5M
- RERE 1.2M
- Earning Date
- KURA 05-01-2025
- RERE 05-19-2025
- Dividend Yield
- KURA N/A
- RERE N/A
- EPS Growth
- KURA N/A
- RERE N/A
- EPS
- KURA N/A
- RERE N/A
- Revenue
- KURA $53,883,000.00
- RERE $2,237,042,920.00
- Revenue This Year
- KURA $44.32
- RERE $29.57
- Revenue Next Year
- KURA $173.73
- RERE $24.43
- P/E Ratio
- KURA N/A
- RERE N/A
- Revenue Growth
- KURA N/A
- RERE 25.93
- 52 Week Low
- KURA $5.41
- RERE $1.53
- 52 Week High
- KURA $23.48
- RERE $3.70
- Technical
- Relative Strength Index (RSI)
- KURA 48.18
- RERE 38.93
- Support Level
- KURA $5.64
- RERE $2.00
- Resistance Level
- KURA $6.11
- RERE $2.25
- Average True Range (ATR)
- KURA 0.39
- RERE 0.20
- MACD
- KURA 0.10
- RERE -0.02
- Stochastic Oscillator
- KURA 81.01
- RERE 26.96
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About RERE ATRenew Inc.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.